quantum
- Home
- quantum
Public
Opening a new frontier in treating Parkinson’s disease
- Review
- November 11, 2022
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Latest Articles
Archer begins new experiments for its lab-on-a-chip for kidney disease detection
According to the Australian Institute of Health and Welfare, there are more than 1.7 million Australians that live with the biomedical signs of chronic kidney disease. While not all will deteriorate to kidney failure, it leads to the 22,000 deaths annually which could be reduced from earlier detection and better management, an initiative launched by
Read MorePublic
Archer Materials advances Biochip technology with new design for manufacturing to be tested in Finland
Australian semiconductor company Archer Materials (ASX: AXE) has progressed its latest Biochip design to the next phase of development by dispatching it to the VTT Technical Research Centre of Finland Ltd (VTT) for manufacturing. The Biochip’s newest graphene field-effect transistor (gFET) design, which was announced in July 2024, marks a milestone in enhancing it’s functionality,
Read MorePublic
Archer and the World Economic Forum flag groundbreaking strategies for rewiring global value chains
According to the World Economic Forum (WEF), the manufacturing industry will need to undertake a major structural shift in the face of emerging technology, climate change and geopolitical tensions that will be driven by economies of skill where global collaborations will be critical to fortifying value chains amidst ongoing disruptions. The WEF White Paper, From
Read MorePublic
Archer Materials expands Biochip development with a semiconductor foundry in Spain
Working closer towards commercialising its cutting-edge graphene Biochip, semiconductor company Archer Materials (ASX: AXE) has dispatched its latest chip design iteration to a certified foundry in Spain for fabrication through a whole wafer manufacturing run. This move is part of Archer’s ongoing commitment to pushing the boundaries in both quantum computing and medical diagnostics while
Read MorePublic
Archer commences foundry discussions for production of graphene biochip
Australian semiconductor company Archer Materials (ASX: AXE) has taken a major step forward towards the commercialisation of its biosensing graphene transistor technology with the transfer of its chip designs to a commercial foundry to initiate a production run. The company’s partnerships with international semiconductor fabs have advanced this year, with Archer having completed its optical
Read MorePublic
Archer makes breakthrough in development of 12CQ chip by preserving quantum functionality at room temperature in air
Quantum computing has emerged as a cutting-edge field with the potential to revolutionise various aspects of technology, from cryptography and optimisation to drug discovery and artificial intelligence. One critical factor that plays a pivotal role in the performance of quantum computers is the conditions in which their qubit processors are required to operate. They include
Read MorePublic
- 1
- 2
